FDA Approval Sends Shares on a Tear
2023年9月25日 - 11:30PM
AllPennyStocks.com
The morning opened up on a high note for this dually-listed
company as it announced U.S. Food and Drug Administration (FDA)
approval of its Metronidazole Oral Suspension 500mg/5mL ( ATI-1501
)....
To read the full story on AllPennyStocks.com, click
here.
Appili Therapeutics (TSX:APLI)
過去 株価チャート
から 4 2024 まで 5 2024
Appili Therapeutics (TSX:APLI)
過去 株価チャート
から 5 2023 まで 5 2024